Log in
RegisterMultiple Dose, Steady State-Partial reference replicate [Design Issues]
» Please help in understanding whether it is possible to conduct “An open-label, randomized, Multiple Dose, Steady State, two treatments, three periods, three sequence, three way, Reference Replicated crossover bioequivalence study” for USFDA Submission?
Why you are doing multiple dose? FDA does not like multiple dose (unless you are doing b2).
J
Why you are doing multiple dose? FDA does not like multiple dose (unless you are doing b2).
J
Complete thread:
- Multiple Dose, Steady State-Partial reference replicate arl_stat 2018-07-13 13:26 [Design Issues]
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- Multiple Dose, Steady State-Partial reference replicate ElMaestro 2018-07-13 13:42
- Logistic nigthmare Helmut 2018-07-13 14:35
- Multiple Dose, Steady State-Partial reference replicatejag009 2018-07-17 06:34
Ing. Helmut Schütz